Oculus Innovative Sciences' CEO Discusses F1Q13 Results - Earnings Call Transcript

Oculus Innovative Sciences, Inc. (OCLS)

F1Q13 Earnings Call

August 2, 2012 04:30 PM ET

Executives

Dan McFadden – Director Public and IR

Hoji Alimi – Founder and CEO

Greg Gust – Analyst

Bob Miller – CFO

Analysts

Laura Engel – Stonegate

Echo He – Maxim Group

Jack Wallace – Sidoti & Company

Bob Robbins – Robbins Capital Management

Prashant Mehta – NetGain

Presentation

Operator

Good afternoon and welcome to the Oculus Innovative Sciences fiscal first quarter 2013 conference call. My name is Stefani and I will be your coordinator for today's call. AT this time all participants are in a listen-only mode. At the end of the call we will be holding a question-and-answer session with the company management. (Operator Instructions) As a reminder, this call is being recorded for replay purposes. I will now turn the call over to Mr. Dan McFadden. Please proceed sir.

Dan McFadden

Thank you Stephanie. Good afternoon and thank you for joining us. With me on the call are our Founder and CEO, Hoji Alimi, Mr. Greg Gust, dermatology industry analyst and our Chief Financial Officer, Bob Miller. We will open the call with Hoji’s discussion of the business highlights since the last earnings call and the company's execution on a strategic business plan. Next Mr. Gust will provide an overview of the dermatology markets and the role that Microcyn based products can play in these areas. Finally Bob Miller will review the financials and then we will take the questions.

This afternoon Oculus issued a press release detailing fiscal first quarter 2013 financial results and recent corporate developments. A copy of the press release can be downloaded from our website which is www. oculusis.com/ or you can call Investor Relations at 425-753-2105 and we’ll be happy to assist you.

If you liked this article you might like

Skin in the Game: This Dermatology Market Stock Is a Good M&A Bet

Analysts' Actions -- CSX, LinkedIn, Micron and More

Occulus Innovative Sciences (OCLS) Stock Spikes After Receiving New U.S. Patent

Oculus Innovative (OCLS) Is Today's Strong On High Volume Stock

Oculus Innovative Sciences (OCLS) Stock Gains on Earnings Beat